Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Normandton Dec 12, 2024 9:14pm
134 Views
Post# 36360222

RE:RE:RE:RE:RE:Insider activity.

RE:RE:RE:RE:RE:Insider activity. eh "dreamer" you should take the stage and make a big statement on yahoo and stocktwit as you usually do and spread your false reasoning to misslead people once again.   Continue to denigrate your own investment and above all hide under several aliases.   Give us a nice conversation with your multiple nicknames, but be careful not to forget to change your alias when you reply to yourself (like you did in the past and by the way if somebody knows how to share a screenshot on this board let me know). Do not hesitate to call the Oncy janitor or the receptionist to clarify this point and some others like the clinical trials and patents for giving weight to your arguments.  And don't forget to add at the end that we all hope a buyout is coming soon......since it's your humble opinion.
<< Previous
Bullboard Posts
Next >>